Evidence map›Paper›PMID 31506453›Full record

ArticleScientific reports2019

Functional analysis of new human Bardet-Biedl syndrome loci specific variants in the zebrafish model.

Sheila Castro-Sánchez, Paula Suarez-Bregua, Rossina Novas, María Álvarez-Satta, Jose L Badano, Josep Rotllant, Diana Valverde

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An Overview towards Zebrafish Larvae as a Model for Ocular Diseases.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Sheila Castro-SánchezGrupo de Biomarcadores Moleculares, Departamento de Bioquímica, Genética e Inmunología, Facultad de Biología, Universidad de Vigo, Lagoas-Marcosende s/n, 36310, Vigo, Spain. shey.cs9@gmail.com.
Paula Suarez-BreguaDepartment of Biotechnology and Aquaculture, Institute of Marine Research, Spanish National Research Council (IIM-CSIC), Vigo, Spain.
Rossina NovasHuman Molecular Genetics Laboratory, Institut Pasteur de Montevideo, Mataojo 2020, Montevideo, CP11400, Uruguay.
María Álvarez-SattaGrupo de Biomarcadores Moleculares, Departamento de Bioquímica, Genética e Inmunología, Facultad de Biología, Universidad de Vigo, Lagoas-Marcosende s/n, 36310, Vigo, Spain.
Jose L BadanoHuman Molecular Genetics Laboratory, Institut Pasteur de Montevideo, Mataojo 2020, Montevideo, CP11400, Uruguay.ORCID http://orcid.org/0000-0002-0706-8652
Josep RotllantDepartment of Biotechnology and Aquaculture, Institute of Marine Research, Spanish National Research Council (IIM-CSIC), Vigo, Spain.
Diana ValverdeGrupo de Biomarcadores Moleculares, Departamento de Bioquímica, Genética e Inmunología, Facultad de Biología, Universidad de Vigo, Lagoas-Marcosende s/n, 36310, Vigo, Spain. dianaval@uvigo.es.
Consejo Superior de Investigaciones Científicas · ESInstitut Pasteur de Montevideo · UYInstituto de Investigación de Enfermedades Raras · ESInstituto de Investigación Sanitaria de Santiago · ESUniversidade de Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multiple genetic approaches available for molecular diagnosis of human diseases have made possible to identify an increasing number of pathogenic genetic changes, particularly with the advent of next generation sequencing (NGS) technologies. However, the main challenge lies in the interpretation of their functional impact, which has resulted in the widespread use of animal models. We describe here the functional modelling of seven BBS loci variants, most of them novel, in zebrafish embryos to validate their in silico prediction of pathogenicity. We show that target knockdown (KD) of known BBS (BBS1, BB5 or BBS6) loci leads to developmental defects commonly associated with ciliopathies, as previously described. These KD pleiotropic phenotypes were rescued by co-injecting human wild type (WT) loci sequence but not with the equivalent mutated mRNAs, providing evidence of the pathogenic effect of these BBS changes. Furthermore, direct assessment of cilia located in Kupffer's vesicle (KV) showed a reduction of ciliary length associated with all the studied variants, thus confirming a deleterious effect. Taken together, our results seem to prove the pathogenicity of the already classified and unclassified new BBS variants, as well as highlight the usefulness of zebrafish as an animal model for in vivo assays in human ciliopathies.

Indexed as

Genetic LociMutationAnimalsBardet-Biedl SyndromeCohort StudiesCytoskeletal ProteinsDisease Models, AnimalEmbryo, NonmammalianFemaleGroup II ChaperoninsHigh-Throughput Nucleotide SequencingHumansMaleMicrotubule-Associated ProteinsOligonucleotides, AntisensePedigreeBbs1 protein, humanBBS5 protein, humanCytoskeletal ProteinsGroup II ChaperoninsMicrotubule-Associated ProteinsMKKS protein, humanOligonucleotides, AntisensePhosphate-Binding Proteins

Identifiers

PMID31506453
PMCPMC6736949
OpenAlexW2972524442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.